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The p38 mitogen-activated protein kinase (MAPK) signaling pathway is activated by numerous inﬂammatory me-
diators and environmental stresses. We assessed the effects of ultraviolet B (UVB) on the p38 MAPK pathway and
determined whether cyclooxygenase (COX)-2 expression is downstream of this kinase in the skin of UVB-irradiated
SKH-1 mice. SKH-1 mice were irradiated with a single dose of UVB (360 mJ per cm2), and activation of the epidermal
p38 MAPK pathway was assessed. UVB-induced phosphorylation of p38 MAPK occurred in a time-dependent
manner. Phosphorylation of MAPK-activated protein kinase-2 (MAPKAPK-2) also was detected and correlated with
an increase in its kinase activity. Phosphorylation of heat shock protein 27 (HSP27), a substrate for MAPKAPK-2,
also was detected post-irradiation. Oral administration of the p38 inhibitor, SB242235, prior to UVB irradiation,
blocked activation of the p38 MAPK cascade, and abolished MAPKAPK-2 kinase activity and phosphorylation of
HSP27. Moreover, SB242235 inhibited expression of the pro-inﬂammatory cytokines interleukin (IL)-6 and KC
(murine IL-8) and COX-2. Our data demonstrate that UVB irradiation of murine skin activates epidermal p38 MAPK
signaling and induces a local pro-inﬂammatory response. Blockade of the p38 MAPK pathway may offer an ef-
fective approach to reducing or preventing skin damage resulting from acute solar radiation.
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p38 mitogen-activated protein kinase (MAPK) belong to a
highly conserved family of serine/threonine protein kinases
that include extracellular signal-regulated protein kinases
(ERK) and c-Jun N-terminal kinases (JNK). p38 MAPK is
involved in numerous cellular processes, such as cell
growth and survival, differentiation, development, cell cy-
cle regulation, and cell death, depending on the cell type
and stimulus (Juretic et al, 2001; Yosimichi et al, 2001). The
ERK pathway is generally activated by mitogenic stimuli,
whereas the JNK and p38 pathways are activated by pro-
inflammatory or stressful stimuli. Various stressors, such
as ultraviolet (UV) radiation, oxidative injury, heat shock,
cytokines, and other pro-inflammatory stimuli, are known to
trigger induction of the p38 MAPK-dependent signaling
cascade. p38 MAPK exists as four isoforms (a, b, g, and d)
and is activated by several upstream kinases in vitro, in-
cluding MAP kinase kinases (MKK) 3, 4, and 6 (Kyriakis and
Avruch, 2001). Phosphorylation of p38 MAPK in turn acti-
vates numerous downstream substrates, including p90
MAPK-activated protein kinase-2 (MAPKAPK-2) (Maizels
et al, 2001) and mitogen and stress-activated kinase-1/2
(MSK1/2) (Deak et al, 1998). p90 MAPKAPK-2 and MSK1/2
function to phosphorylate heat shock protein 27 (HSP27)
and cAMP-response element binding protein transcriptional
factor, respectively (Kato et al, 2001; Wiggin et al, 2002).
Other transcription factors, including activating transcrip-
tion factor 2, Elk, CHOP/GADD153, and myocyte enhancer
factor 2, are known to be regulated by these kinases (Shi
and Gaestel, 2002).
Exposure of skin to both acute and chronic solar UVB
radiation is the major known environmental agent driving
the development of basal cell carcinomas and squamous
cell carcinomas (SCC), also known as non-melanoma skin
cancers. These are the most common types of human ma-
lignancy affecting more than one million Americans each
year. In addition to its direct mutagenic effects, UVB induc-
es inflammatory responses that are critical for tumor induc-
tion (Wilgus et al, 2002). The UVB-induced inflammatory
response is characterized by the acute development of ed-
ema and erythema, and increases in dermal inflammatory
cell infiltrates and augmented prostaglandin synthesis
(Hruza and Pentland, 1993; Terui and Tagami, 2000).
Cyclooxygenases (COX) convert free arachidonic acid
into a series of pro-inflammatory eicosanoids including
prostaglandins. The COX-1 isoform serves as a house-
keeping enzyme and is expressed in most tissues, whereas
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COX-2 is an inducible isoform generated in response to pro-
inflammatory stimuli, including cytokines. The role of p38
MAPK in UVB-induced COX-2 expression has been docu-
mented by several laboratories using a human keratinocyte
cell line, HaCaT. In this cell system, p38 MAPK, but not ERK,
was required for UVB-induced COX-2 expression (Chen
et al, 2001). In contrast, Ashida et al (2003) recently reported
that UVB induction of COX-2 is associated with the activa-
tion of EGFR, ERK, p38 MAPK, and PI (phosphatidylinositol)
3-kinase. p38 MAPK transcriptionally regulates COX-2 in
HaCat cells following UVB irradiation (Chen et al, 2001; Tang
et al, 2001). The involvement of p38 MAPK in regulation of
the stability of the COX-2 message was also demonstrated
in interleukin (IL)-1-treated HeLa cells and lipopolysaccha-
ride-treated primary human monocytes (Ridley et al, 1998;
Dean et al, 1999; Lasa et al, 2000). These data suggest that
UVB-induced p38 MAPK activity and its attendant pro-in-
flammatory signaling are involved in the pathogenesis of
skin disorders including SCC.
In this study, we have assessed the in vivo effects of UVB
irradiation on acute inflammatory responses in SKH-1 hair-
less mice, a well-established model for UVB-induced skin
carcinogenesis. Our data indicate that acute UVB exposure
induces the rapid activation of the p38 kinase signaling
cascade, leading to COX-2 and pro-inflammatory cytokine
production. Furthermore, oral administration of a p38 MAPK
inhibitor abrogated these UVB-mediated inflammatory re-
sponses.
Results
UVB activates p38 MAP kinase signaling in murine
skin Irradiation of SKH-1 mice with a single dose of 360 mJ
per cm2 of UVB-induced consistent visible erythema and
edema, and this dose was used throughout this study. To
demonstrate that UVB-induced activation of p38 MAPK
signaling in vivo, mice were irradiated and sacrificed at var-
ious time points thereafter (0.5, 2, 8, and 24 h). Dorsal skin
patches were excised and the dermis was removed by
scraping, and extracts of the epidermal samples were pre-
pared as described in Materials and Methods. Rapid phos-
phorylation of p38 MAPK was documented following
analysis of these extracts by western blotting using a
phospho-specific antibody (Fig 1). p38 MAPK phosphor-
ylation was detected as early as 30 min post-irradiation, and
was maximal at 24 h. No phosphorylation was detected
in non-irradiated skin. Phosphorylation of MAPKAPK-2, a
downstream substrate of p38 MAPK, was detected 30 min
post-irradiation and gradually increased to its maximum
level by 24 h. The total endogenous p38 MAPK and MAP-
KAPK-2 levels were not altered by UVB irradiation (Fig 1).
Western blot analysis also demonstrated that kinases up-
stream of p38 (MKK3/6) were phosphorylated immediately
following UVB irradiation (data not shown).
UVB induces phosphorylation of MAPKAPK-2 at Thr 222
and Thr 334 MAPKAPK-2 activation by p38 MAPK requires
the phosphorylation of two threonine sites at positions 222
and 334. We assessed the phosphorylation pattern of these
two residues after UVB irradiation. Skin sections from UVB-
irradiated and non-irradiated mice were subjected to
immunohistochemical staining using Thr222- and Thr334-
phospho-specific MAPKAPK-2 antibodies. Phosphorylated
MAPKAP-2 proteins in both residues were detectable
throughout the epidermis following UVB irradiation, and
24 h later, all epidermal cells stained positively for the
phospho-MAPKAPK-2 protein (Fig 2). The staining was
minimal in the non-irradiated control skin. To distinguish the
basal layer staining, the skin section (1 h post-UVB) was
stained for proliferating cell nuclear antigen (PCNA), which
is an established marker of cellular proliferation in both nor-
mal and neoplastic tissues and is required for DNA repli-
cation. PCNA expression was noted to be more intense in
the basal layer (Fig 2f).
UVB-induced MAPKAP kinase-2 activity correlates with
HSP27 phosphorylation MAPKAPK-2 kinase activity was
assessed in UVB-irradiated skin extracts by immunopre-
cipitating with an anti-MAPKAPK-2 antibody and assaying
these complexes for kinase activity, using an MAPKAPK-2
substrate peptide; incorporation of 32P-ATP into the subst-
rate peptide was measured by scintillation counting. Figure
3B compares MAPKAP kinase-2 activity in the non-irradi-
ated control skin and the UVB-irradiated skin at 1, 3, and
24 h post-irradiation. Compared with the non-irradiated
control, a 5-fold (p¼ 0.018) increase in kinase activity was
observed at 3 h, and increases of 2.5-fold (p¼0.032) and
4.4-fold (p¼0.003) were observed at 1 and 24 h, respec-
tively. Moreover, activation of MAPKAPK-2 correlated with
the appearance of phospho-HSP27 substrate (Fig 3A).
These data indicate that a single skin exposure to UVB
activates the p38 MAPK signaling cascade in the skin of
SKH-1 hairless mice. This finding is consistent with studies
demonstrating that p38 kinase is involved in responses to
UVB in murine and human cells in vitro (Bulavin et al, 2001).
The p38 MAPK inhibitor SB242235 abolishes MAP-
KAPK-2 activity and HSP27 phosphorylation To further
explore the role of p38 in mediating UVB-induced inflam-
matory responses, we administered the p38 MAPK inhibitor
Figure1
p38 mitogen-activated protein kinase (MAPK) pathway is activated
by ultraviolet B (UVB) irradiation of murine skin in vivo. Total and
phosphorylated levels of p38 MAPK and MAPK-activated protein kin-
ase-2 (MAPKAPK-2) were detected by western blotting of epidermal
extracts prepared from non-irradiated control (lane 1) and UVB-irradi-
ated skin (lanes 2–5). Mice were sacrificed at 30 min (lane 2), 2 h (lane
3), 8 h (lane 4), and 24 h (lane 5) after UVB irradiation. Each lane con-
tains 80 mg of protein lysate.
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SB242235 (Badger et al, 2000a, b) orally to mice 30 min
prior to UVB irradiation. Epidermal extracts from these mice
were analyzed for HSP27 phosphorylation by western blot-
ting (Fig 4A) and for MAPKAPK-2 kinase activity (Fig 4B). As
shown in Fig 4A, HSP27 phosphorylation induced by UVB
was abolished at 1 h (lanes 3–6) and significantly reduced at
3 h (lanes 7–10) and 24 h (lanes 11–14) in mice treated with
SB242235, relative to vehicle-treated controls. The level of
total endogenous HSP27 is not altered by UVB irradiation
(Fig 4A). SB242235 treatment completely abolished MAP-
KAPK-2 kinase activity at the earlier time points (1 and 3 h),
which was returned to baseline at 24 h (Fig 4B). Figure 4C
compares the level of MAPKAPK-2 kinase activity observed
in the skin of SB242235-treated animals (dotted line) with
plasma concentration of SB242235 (solid line) at 1, 3,
and 24 h post-UVB irradiation. Plasma concentrations of
SB242235 (4.5 mg per mL) were maximal at 1 h post-dose
and gradually decreased; at 24 h, no plasma-associated
drug was detectable.
p38 inhibition blocks UVB-induced COX-2 expres-
sion We have previously shown that COX-2 expression is
enhanced by UVB irradiation and that COX-2 is overex-
pressed in UVB-induced SCC in SKH-1 mice (Athar et al,
2001; An et al, 2002). We therefore determined whether p38
MAPK could be involved in UVB-induced COX-2 expres-
sion. Mice were irradiated with UVB and COX-2 protein
detected by western blotting of epidermal extracts. COX-2
protein was detectable 3 h following UVB irradiation (lanes
7–10) and increased further by 24 h (lanes 11–14) (Fig 5A).
Non-irradiated epidermal samples (two mice: lanes 1 and 2)
and the irradiated epidermis at 1 h following UVB (lanes
3–6) showed no detectable COX-2 protein. SB242235 ad-
ministration significantly reduced the level of COX-2 protein
observed 3 h after UVB irradiation. COX-2 expression,
however, was observed in some animals at the 24 h time
point. Since COX-2-derived metabolites are components of
inflammatory responses, we asked whether the p38 MAPK
inhibitor influenced the development of UVB erythema.
UVB-induced erythema in these mice generally peaks 5 d
after exposure. Figure 5B shows a representative picture of
animals exposed to 360 mJ per cm2 on day 5 (left panel: a).
Figure 2
Ultraviolet B (UVB) induces phosphorylat-
ion of mitogen-activated protein kinase-
activated protein kinase-2 (MAPKAPK-2)
in murine epidermis. Immunohistochemi-
cal detection of phospho-MAPKAPK-2 in
UVB-irradiated murine skin sections, using
phospho-specific antibodies for Thr334 (A)
and Thr222 (B), in non-irradiated control skin
(a, g) and skin prepared 15 min (b, h), 1 h (c,
i), and 24 h (d, j) after UVB irradiation (360
mJ per cm2). (e, l), which were adjacent
sections of (c) and (i), respectively, stained
omitting anti-phospho-specific antibodies
for Thr334 and Thr222. (k) A non-irradiated
murine skin section, stained omitting anti-
phospho-specific antibodies for Thr222. (f)
One hour post-irradiation, stained with anti-
proliferating cell nuclear antigen (PCNA) an-
tibody. The arrows indicate the cells that
stained positively for phospho-MAPKAPK-2.
(magnification:  200; Scale bar¼ 100mm).
Figure 3
Ultraviolet B (UVB)-induced mitogen-activated protein kinase-ac-
tivated protein kinase-2 (MAPKAPK-2) kinase activity correlates
with heat shock protein 27 (HSP27) phosphorylation. (A) The pres-
ence of phosphorylated HSP27 in epidermal extracts was detected
by western blotting using a phospho-specific HSP27 antibody. Total
HSP27 is shown as a control. Each lane contains 80 mg of protein. (B)
MAPKAPK-2-associated kinase activity was measured in UVB-irradi-
ated skin extracts. MAPKAPK-2-dependent protein kinase was
immunoprecipitated from 250 mg of protein lysate, and its kinase ac-
tivity was assayed using substrate peptide and g-32P-ATP; incorpora-
tion of 32P into the peptide was measured by scintillation counting.
Kinase activity of the non-irradiated control was compared with
samples taken at 1, 3, and 24 h following UVB irradiation. Each point
represents the mean of four animals. p-values, compared with
non-irradiated control.
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Variable erythema was seen in these four mice, likely re-
flecting the fact that the animals are free to move around the
cage during irradiation. Typically, four mice in a cage are
irradiated simultaneously. Although the degree of redness
varied among the four animals, each showed clear evidence
of erythema. A single oral dose of SB242235 administered
30 min prior to UVB irradiation virtually eliminated the de-
velopment of erythema in these mice (right panel: b).
UVB-induced pro-inﬂammatory cytokine production is
blocked by the p38 inhibitor Keratinocytes are major
contributors to epidermal cytokine production either con-
stitutively or in response to various stimuli involved in the
inflammatory responses, as well as cell proliferation and
differentiation processes (Grone, 2002). IL-6 and IL-8 are
among the best-characterized keratinocyte-derived pro-in-
flammatory cytokines (Ansel et al, 1990; Luger et al, 1990;
McKenzie et al, 1994). IL-6 is induced in keratinocytes ex-
posed to UVB radiation or treated with TGF-a (Aragane
et al, 1996; Pupe et al, 2002), and is reported to drive ker-
atinocyte proliferation associated with epidermal hyperpl-
asia (Grossman et al, 1989; Turksen et al, 1992; Sawamura
et al, 1998). IL-8 is a potent neutrophil attractant and ac-
tivator. The mouse homolog of IL-8 is known as KC, the
production of which is increased in various inflammatory
conditions (Farone et al, 1995; Godiska et al, 1995). Its ac-
tivity is mediated by the murine IL-8 receptor. We assessed
the production of IL-6 and KC in UVB-irradiated murine
epidermis and determined whether p38 MAPK was involved
in their production. The levels of both KC and IL-6 increased
substantially in response to UVB, showing a 9-fold
(p¼0.0007) and 3-fold (p¼0.001) induction, respectively,
at 24 h after irradiation, as compared with the non-irradiated
control (Fig 6). A significant reduction in the levels of KC
and IL-6 was observed with SB242235 treatment. These
results demonstrate that the p38 MAP kinase signaling
pathway is necessary for UVB-induced cytokine expression
in murine skin.
Figure 4
Oral administration of SB242235 inhibits mitogen-activated protein
kinase-activated protein kinase-2 (MAPKAPK-2) activity and heat
shock protein 27 (HSP27) phosphorylation in skin in vivo. A total of
24 SKH-1 hairless mice were divided into two groups. One group of 12
animals received orally administered SB242235 30 min prior to ultra-
violet B (UVB) irradiation (360 mJ per cm2). Controls received vehicle
only. Four mice from each group were sacrificed at 1, 3, and 24 h
following irradiation. (A) The effect of SB242235 on UVB-induced
HSP27 phosphorylation was assayed by western blotting. Lanes 1–2:
non-irradiated control epidermal extracts and lanes 3–14: epidermal
extracts from UVB-irradiated skin. (B) Effects of SB242235 on UVB-
induced MAPKAPK-2 kinase activity. Epidermal extracts from four mice
for each time point were assayed for MAPKAPK-2 kinase activity. Kin-
ase activity recovered in skin from mice treated with (þ ) or without ()
SB242235 was compared with that associated with non-irradiated
control skin samples. Each point represents the mean of four animals.
Compared with lane 1;  and compared with lanes 3 and 4, re-
spectively. (C) Plasma concentration of SB242235. The solid line indi-
cates SB242235 plasma concentration at 1, 3, and 24 h following UVB
irradiation. The dotted line indicates the MAPKAPK-2 kinase activities
measured in skin samples from these same animals. Each point rep-
resents the mean of four animals.
Figure 5
Inhibition of ultraviolet B (UVB)-induced cyclooxygenase (COX)-2
expression and UVB erythema by SB242235. (A) COX-2 protein was
determined by western blotting using anti-COX-2 antibody, 80 mg of
protein per lane. (B) SKH-1 mice were treated with either SB242235 or
the vehicle 30 min prior to UVB irradiation (360 mJ per cm2). The mice
were inspected daily basis for the appearance of erythema on UVB-
irradiated dorsal skin. Pictures were taken on day 5 following irradi-
ation. The left panel (a) shows vehicle-treated controls, and the right
panel (b) shows animals treated with SB242235.
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Discussion
Sunburn is a visible cutaneous manifestation of activation of
inflammatory signaling pathways resulting from environ-
mental exposure to solar radiation, particularly UVB. Fur-
thermore, sun exposure is clearly the most important factor
in the development of skin cancer. In this study, we used
SKH-1 hairless mice to determine the role of the p38 MAPK
signaling pathway in the inflammatory response to UVB.
Our results demonstrate that UVB activates the p38 MAPK
pathway, inducing acute inflammatory responses and ery-
thema. The time-dependent activation of p38 MAPK signa-
ling correlates with UVB-mediated elaboration of the pro-
inflammatory cytokines IL-6 and murine KC (IL-8), as well as
COX-2. p38 MAPK pathway activation was confirmed by
detecting phosphorylation of MAPKAPK-2 and HSP27 and
by directly measuring the kinase activity of MAPKAPK-2.
Phosphorylation of MAPKAPK-2 occurred rapidly (within
15 min) after UVB exposure, suggesting that p38 MAPK
signaling is involved in the immediate response to this form
of energy. Acute responses to UVB are driven by inflam-
matory pathways and may reflect the direct effects of ab-
sorbed photons on DNA (Tedesco et al, 1997), through the
involvement of UVB-generated reactive oxygen species
(Athar et al, 1989; Dalle Carbonare and Pathak, 1992), or the
generation of prostaglandins and other cytokines (Pentland
and Needleman, 1986; Kupper, 1990; Soter, 1990).
Synthesis of many cytokines, such as tumor necrosis
factor-a (TNF-a), IL-1, IL-6, IL-10, and IL-8, is induced by
UVB in keratinocytes (Konnikov et al, 1989; Kirnbauer et al,
1991; Grandjean-Laquerriere et al, 2002), and these drive
cutaneous inflammatory responses (Kondo, 1999). p38
MAPK is an important component of cytokine signaling
pathways (Allen et al, 2000). In A431 cells, for example, p38
MAPK mediates IL-6 synthesis in response to IL-4, and in-
hibition of p38 MAPK reduces the stability of IL-6 mRNA
(Wery-Zennaro et al, 2000). Our results show that IL-6 and
KC (IL-8) are induced in SKH-1 murine skin following UVB
irradiation. Furthermore, oral administration of the p38
MAPK inhibitor SB242235 completely inhibited the produc-
tion of these cytokines as well as COX-2 expression, sug-
gesting that regulation of COX-2 is dependent on p38
MAPK. Recently, MAPKAPK-2 was shown to contribute to
increased COX-2 mRNA stability following taxane treat-
ment, and a selective p38 MAPK inhibitor suppressed
taxane-mediated COX-2 stimulation in human mammary
epithelial cells (Subbaramaiah et al, 2003).
Following oral administration of SB242235, the UVB-in-
duced inflammatory response was attenuated. This agent
effectively suppressed activation of MAPKAPK-2 and phos-
phorylation of HSP27 following UVB irradiation. SB242235
also suppressed UVB-induced induction of COX-2 and the
cytokines IL-6 and KC. These pharmacological effects were
manifested within 1 and 3 h of irradiation, but returned to
baseline by 24 h. SB242235 demonstrated a short plasma
half-life, and at the dose used in this study, plasma levels of
the compound were undetectable after 24 h, suggesting
that its disappearance coincided with loss of its pharma-
cological effects. Moreover, a single oral dose of SB242235
effectively abrogated erythema development in UVB-irradi-
ated murine skin. The spectral property of SB242235
showed that it absorbs UVR between 290 and 380 nm,
with maximum absorption at 330 nm. In order to determine
whether the oral administration of SB242235 exerts a pho-
toprotective effect in the epidermis, we measured thymine
dimers in epidermal DNA, which is a direct index for DNA
damage following UV radiation of the skin (Antille et al,
2003). We found that UVB irradiation induces the formation
of thymine dimers throughout the epidermis, as demon-
strated by immunohistochemical staining. The number
and density of epidermal nuclei stained for thymine
dimers, however, were not affected by pre-treatment with
SB242235, indicating that intracellular SB242235 is not
functioning as a sunscreen to protect against UVB-induced
DNA damage, and that the SB242235-mediated anti-in-
flammatory response we observed is likely because of in-
hibition of the p38 MAPK pathway (data not shown). Taken
together, our data suggest that pharmacological suppres-
sion of the acute biochemical changes by SB242235 is
sufficient for attenuation of the entire UVB-induced inflam-
matory responses.
Figure 6
Inhibition of p38 mitogen-activated protein kinase signaling leads
to reduced interleukin (IL)-6 and KC (IL-8) production. Inhibition of
KC (A) and IL-6 (B) production by SB242235 administration in epider-
mal extracts, measured at 1, 3, and 24 h after UVB irradiation. p-value
compared with non-irradiated control (lane 1); compared with 3 h
post-irradiation (lane 3); compared with 24 h post-irradiation (land
4). The KC and IL-6 data were derived from a total of four mice for each
time point. Each data point represents the meanþSD.
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Inflammatory cytokines such as TNF-a and IL-1 are
known to regulate IL-6 production (Eliopoulos et al, 1999).
TNF-a-mediated IL-6 induction occurs through stimulation
of nuclear factor-kB (NF-kB), in which p38 MAPK acts as an
activator of IB kinases (Craig et al, 2000). In our study, trace
amounts of TNF-a were detected in response to UVB, using
both western blotting and ELISA (data not shown). It is
known that TNF-a and IL-6 can be differentially regulated in
UVB-irradiated human keratinocytes via the cyclic AMP/
protein kinase A pathway (Grandjean-Laquerriere et al,
2003). IL-6 is overexpressed in some human tumors where
its synthesis is thought to be regulated by the coordinated
activation of the NF-kB and p38 pathways. Inhibition of NF-
kB and p38 MAPK activation can suppress IL-6 synthesis in
prostate cancer cells (Park et al, 2003). Furthermore, po-
tential binding sites for NF-kB, in addition to binding sites
for other transcription factors, are present in the IL-6 pro-
moter (Asschert et al, 1999; Franchimont et al, 1999). UVB is
known to activate NF-kB in both keratinocytes and whole-
skin extracts, linking the p38 MAPK and NF-kB pathways in
response to UVB. The elucidation of the mechanism by
which chronic UVB irradiation induces cytokine synthesis in
the skin, and its link to the p38 MAPK signal transduction
pathways and NF-kB may provide important insights into
the pathogenesis of UVB-induced skin disorders.
Materials and Methods
The medical ethical committee of the University of Columbia ap-
proved all described studies.
Animals Female SKH-1 hairless mice (4–6 wk of age) were pur-
chased from Charles River Laboratories (Kingston, New York). All
experiments were performed in accordance with the Columbia
University Animal Care guideline and protocols. The SKH-1 hairless
mice strain was chosen because these animals can be easily irra-
diated and observed for UVB erythema and tumor induction effects.
In contrast to many other immunodeficient hairless mice strains,
such as BALB/c (nu/nu), SKH-1 mice are immunocompetent.
UV light source and irradiation The UV Irradiation Unit (Daavlin,
Bryan, Ohio) used in this study is described in our previous pub-
lication (Kim et al, 2002). For irradiation, the SKH-1 hairless mice
were exposed to 360 mJ per cm2 of UVB with four mice per cage.
In vivo inhibition of p38 MAPK Mice were fasted overnight with
free access to water. The p38 MAPK inhibitor, SB242235, was
administered by oral gavage, 100 mg per kg body weight in 0.5%
methylcellulose (Sigma-Aldrich, St Louis, Missouri), 30 min prior to
UVB exposure. Control mice were treated with 0.5% methylcellu-
lose suspension alone. All mice were returned to their normal diet
following UVB irradiation. SB242235 was prepared as previously
described (Adams et al, 1998, 2001; Ward et al, 2002).
Immunohistochemical analyses Immunohistochemical staining
was performed as previously described (Kim et al, 2002) using the
following primary antibodies (1:500 dilutions of anti-phospho-
MAPKAPK-2 (Thr334) and anti-phospho-MAPKAPK-2 (Thr222),
Cell Signaling Tech. (Beverly, Massachusetts); anti-PCNA antibody,
Calbiochem (LaJolla, California)).
Western blot Skin specimens from both the UVB-irradiated mice
treated with (þ ) or without () the p38 inhibitor, and the non-
irradiated mice were excised, and the dermis was removed by
scalpel scraping. These epidermal samples were homogenized in a
lysis buffer and western blot analyses were performed as previ-
ously described (Kim et al, 2002). The following antibodies were
used in this study: anti-p38 and anti-HSP27, Santa Cruz Biotech.
(Santa Cruz, California); anti-phospho-MAPKAPK-2 (Thr334), anti-
MAPKAPK-2, anti-phospho-p38 (Thr180/Tyr182), and anti-phos-
pho-HSP27 (Ser82), Cell Signaling Tech.; and anti-COX-2, Cayman
Chemicals (Ann Arbor, Michigan). Antibody-reactive proteins were
detected using ECL reagents according to the manufacturer’s in-
structions (Amersham, Piscataway, New Jersey), with several ex-
posures made on Kodak X-Omat X-ray films.
MAPKAP kinase 2 assay Lysates were pre-cleared with 300 mL of
10% protein G sepharose slurry (Sigma-Aldrich) for 10 min at 41C,
after which supernatants were collected and protein concentration
was determined by DC Bio-Rad assay (Hercules, California). Sam-
ples containing 500 mg of protein were then incubated with 50 mg
sheep anti-rabbit MAPKAP kinase 2 antibody (Upstate Biotech.,
Waltham, Massachusetts) in 500 mL buffer A (50 mM Tris, pH 7.5,
1% Triton X-100, 50 mM sodium fluoride, 10 mM b-glycerol phos-
phate, 1 mM EDTA, 1 mM EGTA, 0.5 mM sodium orthovanadate,
1 mM DTT, 0.1 mM PMSF, 10 nM okadaic acid, 5 mM sodium
pyrophosphate, and complete EDTA-free protease inhibitor cock-
tail (Roche Applied Science, Indianapolis, Indiana) for 2 h at 41C.
Three hundred microliters of 10% protein G sepharose slurry was
then introduced and the mixture was incubated for 1 h at 41C. The
beads were collected by centrifugation at 3000 r.p.m. (  0.8 g) for
3 min at 41C. Immune complexes were washed once in 0.5 mL of
buffer A, containing 0.5 M NaCl; once in 1 mL of buffer A; and once
in 0.5 mL of ADB buffer (20 mM MOPS, pH7.2; 25 mM b-glycerol
phosphate; 5 mM EGTA; 1 mM sodium orthovanadate; and 1 mM
DTT). Finally, the bead pellets were suspended in 40 mL of ADB
buffer supplemented with 125 mM ATP, 10 mM MgCl2, 100 mM
MAPKAP kinase 2 substrate peptide (Upstate Biotech.), and 10 mCi
[g-32P]ATP (Amersham). The kinase reaction was allowed to pro-
ceed at 301C for 30 min, after which 25 mL of each reaction mixture
was spotted onto individual p81 phosphocellulose filters (What-
man, Clifton, New Jersey). These filters were washed with four
changes of 0.75% phosphoric acid, once with acetone, air-dried,
and then analyzed in a scintillation counter for 32P.
Measurement of plasma concentration of SB242235 Approxi-
mately 0.5 mL of blood was collected at each time point by cardiac
puncture. Plasma was isolated using a Microtainer tube with
lithium heparin, according to the manufacturer’s protocol (Bec-
ton Dickinson, Franklin Lakes, New Jersey). Quantification of
SB242235 was conducted by high-pressure liquid chromatogra-
phy with mass spectrophotometric detection following organic
solvent extraction from plasma.
IL-6 and KC ELISA Extracts prepared from UVB irradiated and
control skin were analyzed for IL-6 and KC ELISA (Mouse IL-6
ELISA, Ebioscience, San Diego, California, standards and samples
diluted in PBS containing 1.0% FBS; Mouse KC ELISA, R&D Sys-
tems (Minneapolis, Minnesota), standards prepared in RD5-3 dilu-
ent with samples diluted 2  in RD5-3 diluent). The assay was
performed following the manufacturers’ guidelines.
Statistical analyses Statistical analyses were performed using
Student’s t test (two-tailed): po0.05 was considered to be statis-
tically significant.
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